Member Info for Larus

The codes are BS. You really need to have a word with yourself if you think the latest appointment is going to have a material effect on the company's bottom line. And once again, the RNS clearly states profitability across all divisions expected this financial year. Not 2021 as you persistently claim for reasons known only to yourself.

Notice how most of the buys are going through on NEX and the sells on LSE :-/

https://www.lse.co.uk/ShareTrades.asp?shareprice=OPTI.GB.PL&share=Optibiotix-Health-Plc

You do realise that the expiry date of these shares is 30th November?

You will of course have read in the latest results that the company expects each of its divisions to reach profitability in the *current* financial year.

Looks as though the Seed probiotic (which includes LPLDL) is in phase 2 trials for IBS....

https://www.prnewswire.com/news-releases/fda-authorizes-new-ind-to-evaluate-impact-of-multi-strain-probiotic-ds-01-on-gut-microbiota-of-patients-with-ibs-301139955.html

Someone on twitter has noticed that the 2,418,608 on the late trades corresponds to the uneven digits of Acacia's holding. So maybe whoever they transferred to has just finished selling them off

So what?

Unlikely that a quarantine lab doing trials on covid19 vaccines will be in the same building as a covid19 hospital. It's called quarantine for a reason

Profitability and hVIVO at full capacity are one thing, but once you take off the value of what the company physically owns, then even at this price the mcap is silly (clue - how much is a 24 bed quarantine clinic and virology lab actually worth to buy now in the middle of a global pandemic?).. and then there's Imutec, the genomic database etc etc....

Whatever value the contract brings, it will put Hvivo/Orph on to the radars of many many more investors than ever before... which is not exactly shabby

"Institutions don’t get it wrong many times" HAHA go pull the other one

https://www.lse.co.uk/rns/CIP/divestment-of-circassia-group-plc-si44nvxq6claw2r.html

CIP Merchant Capital RNS this morning confirming they are fully out or Circassia https://www.lse.co.uk/rns/CIP/divestment-of-circassia-group-plc-si44nvxq6claw2r.html

If you are seeing a daily RSI at 70 as overbought, a look back at previous sustained periods of this share being overbought are when the price experiences steady or high gains (ie Jan/Feb this year and last July). Such periods are an indicator to many buyers to step in

If you look at the weekly chart, 51p is notable as being the high just after listing, and was again resistance a few weeks ago. The chart shows an obvious cup. 51p this week however coincided with resistance on the platinum chart at 1000. https://twitter.com/MrLarus/status/1288015601689133057

Hydrogen engine should do the trick, nothing like a massive ball of flames to impress the yanks :-D

If you look at the most recent interview, Cathal states that they are already on the cusp of profitability

Hilarious - you go to all that length and spend all morning deramping a share then finish it all off by lying about a TR1. Or did you not understand it?

....and debt-free!

Clearly you don't know how subscription shares work if that's what you think.

If GCL is 28p in November GCS will be worth 0p. Good luck!